Bruker | BRKR - Current Liabilities


Bruker reported $1.36B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
ABB USD 18.51B 2.09B Mar/2026
Agilent USD 2.27B 35M Mar/2026
Ametek USD 2.76B 86.62M Mar/2026
Bio Techne USD 153.28M 12.85M Mar/2026
Bio-Rad Laboratories USD 917M 400M Mar/2026
Bruker USD 1.36B 75.9M Mar/2026
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Danaher USD 7.46B 653M Mar/2026
Fujikura JPY 277.92B 13.32B Mar/2026
Furukawa JPY 64.48B 18.99B Dec/2025
General Electric Aerospace USD 40.03B 1.05B Mar/2026
Hitachi JPY 7.17T 195.03B Mar/2026
Illumina USD 1.57B 19M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
Mettler Toledo International USD 1.11B 89.76M Mar/2026
Mitsubishi Electric JPY 1.92T 105.56B Dec/2025
Mitsubishi Heavy Industries JPY 4.26T 524.11B Mar/2026
Myriad Genetics USD 130.2M 3.6M Mar/2026
Nikon Corporation JPY 328.3B 40.08B Mar/2026
Olympus JPY 436.87B 36.14B Mar/2026
Repligen USD 126.21M 9.62M Mar/2026
Revvity USD 1.24B 92.6M Mar/2026
Smiths GBP 1.01B 48M Jun/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Waters USD 1.24B 11.8M Dec/2025